Navigation Links
Gaza strip families give first clue to condition causing blindness and tooth decay
Date:2/12/2009

Scientists studying an inherited condition resulting in blindness and crumbling teeth have found a single defective gene can affect both eye function and normal tooth development.

A previously undiscovered and unexpected link between the formation of teeth and eyes has been uncovered by researchers from the University of Leeds, through studies in two families living in a village in the war-torn Gaza strip.

Funded by the Wellcome Trust and Yorkshire Eye Research, the project team sought to identify the cause of a condition they named Jalili syndrome, in which related individuals suffered loss of eyesight, almost from birth, and poorly developed teeth.

Chris Inglehearn, Professor of Molecular Ophthalmology at Leeds Institute of Molecular Medicine, said: "What interested us was the idea that there might be a single process or protein essential in both teeth and eyes, not something you'd normally think of as having much in common.

"Working with colleagues in the Leeds Dental Institute, genetic changes were found that disrupt the function of a protein called CNNM4 and that are passed on from one generation to the next in these families. This protein is present in the cells that lay down tooth enamel and also in the various layers of the retina, the light sensitive 'film' at the back of the eye."

Prof Inglehearn added that little is yet known about the role of this vital protein but it is possible that it is involved in transporting magnesium or calcium to cells in the body. Both minerals are known to be important in visual function and in teeth and bone formation.

Although a rare condition, Jalili syndrome sufferers from France, Scotland, Iran, Bosnia and Guatemala were also studied. Further research could help scientists gain a better understanding of more common forms of blindness, weak teeth and bone diseases such as osteoporosis, and in time may lead to better treatments.

The possibility of using gene replacement therapy to reverse the effects of this condition is still a long way off and would need to be applied soon after birth to be effective.

Martin McKibbin, Consultant Ophthalmologist at St James University Hospital and Chair of Yorkshire Eye Research, said: "The findings of this research are surprising but will give doctors and scientists a greater understanding of the causes of inherited blindness and may identify novel treatments in the future.

"Yorkshire Eye Research is pleased to be able to support this and other research projects in Yorkshire. The charity relies on donations from individuals and organisations in Yorkshire to continue its work."

Jalili syndrome is named after team member Ismail Jalili, who travelled regularly to Gaza and the occupied West Bank trouble spots to recruit the Gaza strip families into the research, until the escalation of conflict made such trips impossible.


'/>"/>

Contact: Simon Jenkins
pressoffice@leeds.ac.uk
University of Leeds
Source:Eurekalert

Related medicine news :

1. Neovasc Announces Agreement With LeMaitre Vascular for Exclusive Distribution Rights to its Biological Vascular Strips
2. Crest Whitestrips Introduces a Revolutionary New Teeth Whitening Technology
3. San Diego Attorney Provides Emergency Medical Relief to War Torn Gaza Strip
4. Derma Sciences Announces 3-Year Licensing Deals for Highly Profitable Character Strip Bandages
5. Protect Yourself From Teeth to Toes! Lindsay Price and Crest Whitestrips Daily Whitening + Tartar Protection Partner to Empower Women for the 9th Annual National Womens Health Week
6. Pinstripe Healthcare Group Adds Veteran HR Executive Warner as Client Services Director
7. Significant Growth for Pinstripe Leads to Need for Larger Facility
8. Novel approach strips staph of virulence
9. Shimp Joins Pinstripe as Director of Client Services for Healthcare Group
10. Rallies in Five Cities Planned on Friday the 13th to Protect CA Families From the Bad Budget Deal and Permanent, Deep Cuts to Homecare, Education, and Other Vital Services
11. American Families Unaware of Burn Dangers at Home
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/24/2017)... ... 2017 , ... Donna Parker, L. Ac. reads all sorts of books on ... to be very practical. She wanted to write a guide/workbook that would give readers ... It prompted her in writing “ A Clear Path to a Vibrant Life : ...
(Date:4/24/2017)... ... April 24, 2017 , ... ... PA will be attending the 2017 Oral Reconstruction Foundation’s 2017 Symposium on Tissue ... Oral Reconstruction Foundation will present its annual Global Symposium at the Fontainebleau Hotel ...
(Date:4/23/2017)... ... April 23, 2017 , ... "An event Horizon is ... the process rendered in my Art and Music. These are created as Metaphysical Transformations ... the boundary of mystery culminate to the ultimate singularity.", -- Karen Salicath Jamali , ...
(Date:4/22/2017)... (PRWEB) , ... April 22, 2017 , ... ... to his role as Vice President of Sales and Business Development at OAKWORKS, ... GPO/IDN business partner engagements, business development, and strategic planning for the company. ...
(Date:4/21/2017)... ... April 21, 2017 , ... Contrary ... that youth violence is declining—and at noteworthy rates. Between 2002 and 2014, Salas-Wright ... people involved in violence in the United States. The study, Trends in ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... NeuroVive Pharmaceutical AB (Nasdaq Stockholm: ... preclinical results demonstrating anti-fibrotic effects with NV556, ... (NASH), in an additional well-validated experimental NASH ... previously shown similar anti-fibrotic effects in the ... present novel data demonstrating anti-fibrotic effects of ...
(Date:4/19/2017)... 19, 2017  IRIDEX Corporation (Nasdaq: IRIX ... for the first quarter 2017 after the close of ... team will host a corresponding conference call beginning at ... Investors interested in listening to the conference call may ... or (703) 326-3030 for international callers, using conference ID: ...
(Date:4/19/2017)... , April 19, 2017  Sorrento Therapeutics, Inc. ... clinical-stage biopharmaceutical company developing new treatments for cancer ... closing of its previously announced underwritten public offering ... a public offering price of $2.00 per share, ... offering expenses payable by Sorrento.  The net proceeds ...
Breaking Medicine Technology: